NuGene International Inc (OTCBB:NUGN) Bounces as The Hard Mail Lags on

Once again we have witnessed in recent months an enormous promotional campaign and penny stock run up that has offered us all trading opportunities we live for. This ticker in question is OTCQB:NUGN, or NuGene International Inc (OTCBB:NUGN). Take a look at some key facts and information we have outlined about the NUGN situation. First, the stock initially saw highs of $4.55 a share before the ticker got too overweight and cooled down to lower price levels.NUGN is a confirmed $2.28 million hard mailer promotion featuring none other than Kathy Ireland and the over enthusiastic headline ”Did Kathy Ireland just discover Botox without the needle? Super model Kathy Ireland sells an estimated $2b at retail annually and just partnered with NUGN.”” Of course, wild claims and predictions of share values of over $25 are also made. We’ve all seen situations like this before, haven’t we? NuGene International Inc (OTCBB:NUGN) states its business operations includes developing, manufacturing and marketing of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media.According to the disclaimer, ”Casson Media Group, Inc. (CMG), an affiliated company of MicroCap MarketPlace, has received nine thousand dollars in cash compensation from Result Corporation, a third party shareholder of NUGN to assist in the writing of this Advertisement, and anticipates receiving potential future subscription and advertising revenues, the amount of which is not known and cannot be predicted at this time. Result Corporation, besides compensating CMG, paid $2,280,000 to marketing vendors to cover all the costs of creating and distributing this Advertisement, including printing and postage, in attempt to boost investor and market awareness. According to NUGN, the US Department of Health and Human Services calls regenerative medicine the “next evolution of medical treatments.” The regenerative medical market, which includes cosmeceuticals and pharmaceuticals, was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report.NuGene’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company does actually have two patents pending covering 15 unique applications and inventions. NuGene’s goal is to make use of its cache of knowledge and experience to develop age defying regenerative skincare and hair care products in addition to pharmaceutical products based on the same scientific platform.On June 11, NuGene announced it has begun a study that will allow them to evaluate a medication formulation as an improved method of treating burn wounds. The study, named Comparison of an Allantoin Formulation and Allantoin Formulation with Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing Protocol, begun as soon as this information was released and is scheduled to run through September 1, 2015 but can continue beyond that date if needed.NuGene International Inc (OTCBB:NUGN) will provide the investigational new drug to be used in this study. The study will compare the effect of using Allontoin, a natural chemical compound that is produced by many organisms and is commonly used as an ingredient in skin care products, both with and without NuGene’s proprietary conditioned media of adipose-derived stem cells.Another key factor here to be aware of is the 148,200 shares of Bling Marketing that were acquired on March 27, 2014 for just $37,050. After forward splits, these shares are now 11,144,640 free trading shares of NUGN. Allegedly, it all started in March 2014 when certain investors purchased 148,200 shares at $0.25 apiece for $37,050. Two forward splits later, these now number 11,144,640 free trading shares of NUGN common stock. It’s probably a fair assumption that these shares are being sold out in this recent promotion. Currently trading at a $122.7 million market valuation, NUGN does have $1.3 million in the treasury and growing revenues reporting $723,438 in sales in 2014. In recent history it has (more than likely thanks to the promotional campaign) enjoyed higher liquidity and more trading activity. This makes a great situation for active, smart, and informed traders. In situations like this, tickers can move higher still yet on the short term side of things. Inevitably, this stock will drop in the long term. Either way, with attention on it we see today, this stock will provide price action movements quick traders can easily capitalize on. TEXT: STREETNEWS to 555888 for updates on NUGN and other hot companies.Disclaimer: We have not been compensated for this article and have no position in NUGN.Author: Fritz Westfall of Fast Lane Stocks